Logo

ALCYW

Alchemy Investments Acquisition Corp 1

ALCYW

Alchemy Investments Acquisition Corp 1 • NASDAQ
$0.12 ▼ -24.35% (-0.04)
Market Cap $49.32 M
52w High $0.24
52w Low $0.12
Dividend Yield 0%
P/E 0
Volume 30
Outstanding Shares 403.43M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $0 $0 ▼ $-341.897K ▼ 0% $-0.08 ▼ $0 ▲
Q2-2025 $0 $321.051K ▼ $-220.257K ▲ 0% $-0.049 ▲ $-192.007K ▲
Q1-2025 $0 ▼ $401.439K ▼ $-301K ▼ 0% ▼ $-0.067 ▼ $-273K ▼
Q4-2024 $1.202M ▲ $443.016K ▲ $63.925K ▼ 5.317% ▲ $0.012 ▼ $91.902K ▲
Q3-2024 $0 $158.154K $1.456M 0% $0.13 $-158K

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $319.258K ▲ $9.025M ▼ $8.586M ▲ $-8.124M ▼
Q2-2025 $161.205K ▼ $12.503M ▲ $7.931M ▲ $4.572M ▼
Q1-2025 $351.999K ▲ $12.495M ▲ $7.703M ▲ $4.792M ▼
Q4-2024 $181.174K ▼ $12.098M ▼ $7.005M ▲ $5.094M ▲
Q3-2024 $339.638K $125.905M $6.517M $-5.953M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q1-2025 $-301.497K ▼ $-429.175K ▼ $0 ▼ $600K ▲ $170.825K ▲ $-429.175K ▼
Q4-2024 $63.925K ▼ $-158.464K ▲ $114.358M ▲ $-114.358M ▼ $-158.464K ▲ $-158.464K ▲
Q3-2024 $1.456M ▲ $-232.758K ▼ $0 $0 ▼ $-232.758K ▼ $-232.758K ▼
Q2-2024 $1.314M ▼ $-86.815K ▲ $0 $530K ▲ $443.186K ▲ $-86.815K ▲
Q1-2024 $1.414M $-180.531K $0 $0 $-180.531K $-180.531K

Five-Year Company Overview

Income Statement

Income Statement Alchemy Investments Acquisition Corp 1 is still essentially an empty shell, so its income statement does not reflect a normal operating business. There is no meaningful revenue, no gross profit, and no operating profit from selling products or services. Any reported earnings per share are driven by one-off SPAC-related accounting items and capital structure mechanics, not by ongoing business performance. In practical terms, there is no track record yet of how the future combined company will generate revenue or manage its costs once it is operating as Cartiga in the public markets.

Balance Sheet

Balance Sheet The balance sheet is very light, which is typical for a SPAC vehicle. It shows a small pool of assets and equity and no visible debt at this level, suggesting a clean but minimal financial base. This reflects the fact that Alchemy is a temporary financing shell, not a fully operating business. The real balance sheet story will begin only after the merger, when Cartiga’s litigation finance assets, funding lines, and risk exposures appear on the combined company’s books. Until then, the current balance sheet mainly signals low leverage but also very limited scale.

Cash Flow

Cash Flow Cash flow information is effectively blank, with no operating cash inflows or outflows and no investment spending, which aligns with the company’s status as a non-operating SPAC. There is no evidence yet of how the future business converts its activities into cash, how volatile cash flows might be, or how much reinvestment will be required. The true cash flow profile will depend on Cartiga’s litigation funding model, the timing of case resolutions, and how quickly funded claims turn into cash recoveries once the combined business is live.

Competitive Edge

Competitive Edge On its own, Alchemy has no real competitive position; it is a capital-raising shell. The strategic interest lies in its planned merger with Cartiga, a specialist in litigation finance built around a large proprietary legal claims database and advanced data analytics. Cartiga’s long operating history, extensive network of law firm relationships, and integrated offerings for both plaintiffs and law firms create meaningful barriers for new entrants. Its data advantage and underwriting expertise can support more informed risk-taking than smaller or less sophisticated competitors. However, litigation finance is a niche but increasingly crowded field, with legal, regulatory, and reputational risks, and performance is highly dependent on case selection and legal outcomes. Execution after going public will be key to maintaining and expanding this advantage.

Innovation and R&D

Innovation and R&D The core innovation story sits with Cartiga rather than Alchemy itself. Cartiga has spent heavily building a proprietary technology and data platform, including a very large history of funded legal claims and outcomes. It uses data science and machine learning to assess the risk and value of cases, monitor them over time, and optimize portfolio construction. This data-centric approach, combined with tools that help law firms manage their own case portfolios, gives the business both a product edge and the potential to evolve toward a software and analytics revenue stream in addition to financing income. The opportunity is substantial, but so are the execution risks: model quality, data governance, and the ability to keep improving the technology as competitors adopt similar tools will all matter.

Summary

ALCYW represents a security tied to a SPAC that is in the process of bringing Cartiga, a data-driven litigation finance platform, to the public markets. The current financials mainly reflect a clean, small shell with no operating revenue, no meaningful cash flows, and minimal assets, which is normal for this type of vehicle but offers little insight into the future operating business. The investment story centers on Cartiga’s use of proprietary legal data, analytics, and long-standing law firm relationships to underwrite and manage litigation-related assets more intelligently than traditional players. If the merger completes, the key areas to watch will be: how consistently the combined company can translate its data advantage into profitable, diversified portfolios of legal claims; how volatile results are across legal cycles; how well it scales via acquisitions and product expansion; and whether it can turn its technology into recurring, fee-based services for law firms. Overall, this is an early-stage, transition situation where the real fundamentals will only become visible after the operating business is fully reflected in public financial statements.